Early promise for a blood thinner without the bleeding risk
U.S. News and World Report: Alvin Schmaier, the Robert W. Kellermeyer Professor of Hematology/Oncology, commented on the significance of an experimental drug that appears to prevent dangerous blood clots, without raising the risk of excessive bleeding.
